Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Wasamoto

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cureus|March 19, 2025
Pleomorphic Lung Carcinoma Response to Treatment With BRAF and MEK Inhibitors: A Case ReportHideki Endoh, Satoshi Wasamoto
American Journal of Respiratory and Critical Care Medicine|April 21, 2021
Luminal Findings of a Bronchogenic CystSatoru Yanagisawa, Satoshi Wasamoto
Internal Medicine (Tokyo, Japan)|July 23, 2019
Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission TomographySatoru Yanagisawa, Satoshi Wasamoto, Hideki Endoh
American Journal of Respiratory and Critical Care Medicine|October 22, 2025
Cobblestone Airway from <i>Mycobacterium avium</i> InfectionSatoru Yanagisawa, Yuki Todoroki, Hiroki Takechi, et al.
The Clinical Respiratory Journal|September 3, 2024
Atezolizumab-Induced Immune-Related Pneumonia on Rounded AtelectasisSatoru Yanagisawa, Takaya Yui, Hiroki Takechi, et al.
Internal Medicine (Tokyo, Japan)|September 6, 2021
Wheezing and WeightliftingSatoru Yanagisawa, Satoshi Wasamoto, Hiroki Takechi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2025
Stool eosinophils and immune-related adverse event-enterocolitisSatoru Yanagisawa, Takaya Yui, Yuki Kozu, et al.
Respiratory Investigation|November 15, 2020
Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesityAkimasa Sekine, Satoshi Wasamoto, Eri Hagiwara, et al.
Internal Medicine (Tokyo, Japan)|May 15, 2024
Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung CancerSatoshi Wasamoto, Hisao Imai, Takeshi Tsuda, et al.
Cancer Medicine|June 14, 2022
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancerAyako Shiono, Hisao Imai, Satoshi Wasamoto, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cureus|March 19, 2025
Pleomorphic Lung Carcinoma Response to Treatment With BRAF and MEK Inhibitors: A Case ReportHideki Endoh, Satoshi Wasamoto
American Journal of Respiratory and Critical Care Medicine|April 21, 2021
Luminal Findings of a Bronchogenic CystSatoru Yanagisawa, Satoshi Wasamoto
Internal Medicine (Tokyo, Japan)|July 23, 2019
Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission TomographySatoru Yanagisawa, Satoshi Wasamoto, Hideki Endoh
American Journal of Respiratory and Critical Care Medicine|October 22, 2025
Cobblestone Airway from <i>Mycobacterium avium</i> InfectionSatoru Yanagisawa, Yuki Todoroki, Hiroki Takechi, et al.
The Clinical Respiratory Journal|September 3, 2024
Atezolizumab-Induced Immune-Related Pneumonia on Rounded AtelectasisSatoru Yanagisawa, Takaya Yui, Hiroki Takechi, et al.
Internal Medicine (Tokyo, Japan)|September 6, 2021
Wheezing and WeightliftingSatoru Yanagisawa, Satoshi Wasamoto, Hiroki Takechi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2025
Stool eosinophils and immune-related adverse event-enterocolitisSatoru Yanagisawa, Takaya Yui, Yuki Kozu, et al.
Respiratory Investigation|November 15, 2020
Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesityAkimasa Sekine, Satoshi Wasamoto, Eri Hagiwara, et al.
Internal Medicine (Tokyo, Japan)|May 15, 2024
Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung CancerSatoshi Wasamoto, Hisao Imai, Takeshi Tsuda, et al.
Cancer Medicine|June 14, 2022
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancerAyako Shiono, Hisao Imai, Satoshi Wasamoto, et al.
Pageof 2